Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Aimmune Therapeutics hired Dr. Daniel Adelman as chief medical officer. Previously, he was chief medical officer and senior vice president of development at Alvine Pharmaceuticals and held the same positions at Sunesis Pharmaceuticals. He also worked at Pharmacyclics and Genentech.
Bristol-Myers Squibb promoted Murdo Gordon to executive vice president and chief commercial officer;
Valeant Pharmaceuticals named Sam Eldessouky as chief accounting officer;
Biogen promoted Paul McKenzie to executive vice president, pharmaceutical operations & technology;
Johnson & Johnson named Joseph Wolk as director of investor relations, replacing Louise Mehrotra, who is retiring;
Lumos Pharma hired Carol Dutch as senior director of patient engagement;
Neurotrope BioScience hired Dr. Paula Trzepacz as executive vice president and chief medical officer;
Taro Pharmaceutical said Michael Kalb resigned as chief financial officer;
X4 Pharmaceuticals hired John Celebi as chief operating officer;
Leading BioSciences promoted Greg Doyle to chief executive officer;
Ultragenyx Pharmaceutical said Dr. Sunil Agarwal resigned as executive VP and chief medical officer;
Arena Pharmaceuticals hired Kevin Lind as executive vice president and chief financial officer;
Eli Lilly promoted Aarti Shah to senior vice president and chief information officer;
Valeritas Holdings hired David Lewis as vice president of marketing;
NovaBay Pharmaceuticals named Mark Sieczkarek as chief executive officer and president;
Global Oncology, a nonprofit, hired Donna Barry as its first executive director;
Hookipa Biotech hired Jorn Aldag as chief executive officer.